PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 1992Neurology176 citations

N ‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brain

View Full Paper
WKWilliam E. KlunkKPKanagasabai PanchalingamJMJohn Moossy

Key Points

Key points are not available for this paper at this time.

Abstract

We used proton nuclear magnetic resonance spectroscopy in this preliminary study of perchloric acid extracts of 12 Alzheimer's disease (AD) and five control brain samples to measure the relative levels of taurine, aspartate, glutamine, glutamate, gamma-aminobutyric acid (GABA), and the putative neuronal marker, N-acetyl-L-aspartate (NAA). We found no significant changes in taurine, aspartate, or glutamine. NAA was lower in AD compared with control, and this decrease correlated with the number of senile plaques and neurofibrillary tangles in adjacent tissue sections. GABA levels also were lower in AD brain. Glutamate levels were greater in AD than control and showed a close, inverse correlation with NAA levels. These findings suggest that the decrease in NAA reflects neuronal loss and that remaining neurons could be exposed to a relative excess of glutamate and a relative lack of GABA. If present in the neurotransmitter pool, this imbalance could result in neurotoxic cell damage. This hypothesis is further supported by in vitro and in vivo phosphorus 31 nuclear magnetic resonance findings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Klunk et al. (1992) studied this question.

synapsesocial.com/papers/6a210433f58a2e29a03306d8https://doi.org/10.1212/wnl.42.8.1578
Ask AI
Helpful
Bookmark
Share
View Full Paper